[go: up one dir, main page]

PL1704860T3 - Benzamidine derivatives for treatment and prevention of mucositis - Google Patents

Benzamidine derivatives for treatment and prevention of mucositis

Info

Publication number
PL1704860T3
PL1704860T3 PL05102423T PL05102423T PL1704860T3 PL 1704860 T3 PL1704860 T3 PL 1704860T3 PL 05102423 T PL05102423 T PL 05102423T PL 05102423 T PL05102423 T PL 05102423T PL 1704860 T3 PL1704860 T3 PL 1704860T3
Authority
PL
Poland
Prior art keywords
mucositis
benzamidine derivatives
prevention
treatment
epitelium
Prior art date
Application number
PL05102423T
Other languages
Polish (pl)
Inventor
Ornella Letari
Massimo Maria D'amato
Simona Zanzola
Roberto Artusi
Lucio Claudio Rovati
Gianfranco Caselli
Antonio Giordani
Original Assignee
Rottapharm Biotech Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rottapharm Biotech Srl filed Critical Rottapharm Biotech Srl
Publication of PL1704860T3 publication Critical patent/PL1704860T3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)

Abstract

Mucositis is the result of a complex process of interactive biologic phenomena that take place in both the epitelium and the submucosa, often leading to severe pain and increased risk of dangerous systemic infections. Mucositis is often a side effect during chemotherapy and radiation therapy. The benzamidine derivatives herein decribed are particularly effective for treating and preventing mucositis since they are acting simultaneously at the several phases that characterize this disease.
PL05102423T 2005-03-24 2005-03-24 Benzamidine derivatives for treatment and prevention of mucositis PL1704860T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP05102423A EP1704860B1 (en) 2005-03-24 2005-03-24 Benzamidine derivatives for treatment and prevention of mucositis

Publications (1)

Publication Number Publication Date
PL1704860T3 true PL1704860T3 (en) 2011-04-29

Family

ID=35058092

Family Applications (1)

Application Number Title Priority Date Filing Date
PL05102423T PL1704860T3 (en) 2005-03-24 2005-03-24 Benzamidine derivatives for treatment and prevention of mucositis

Country Status (12)

Country Link
US (1) US20080194877A1 (en)
EP (1) EP1704860B1 (en)
JP (1) JP5020227B2 (en)
AT (1) ATE485819T1 (en)
AU (1) AU2006226390B2 (en)
CA (1) CA2600773C (en)
DE (1) DE602005024357D1 (en)
DK (1) DK1704860T3 (en)
ES (1) ES2351665T3 (en)
PL (1) PL1704860T3 (en)
PT (1) PT1704860E (en)
WO (1) WO2006100204A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100190735A1 (en) * 2006-03-28 2010-07-29 Myrex Pharmaceuticals Inc. Mouthwash and Method of Using Same for the Treatment of Mucositis or Stomatitis
US20090092574A1 (en) 2006-12-29 2009-04-09 Scott Richard W Ophthalmic And Otic Compositions Of Facially Amphiphilic Polymers And Oligomers And Uses Thereof
AU2012255935B2 (en) 2011-05-16 2016-06-23 Innovation Pharmaceuticals Inc. Compounds for use in treatment of mucositis
FR2979241B1 (en) 2011-08-30 2014-05-09 Nutrialys Medical Nutrition Sa USE OF LOW-POLYAMINE COMPOSITIONS IN THE PREVENTION OR TREATMENT OF ADVERSE EFFECTS RELATED TO ANTI-CANCER TREATMENT
EP2852571A4 (en) * 2012-05-23 2015-11-25 Cellix Bio Private Ltd Compositions and methods for the treatment of mucositis
US20160199338A1 (en) 2013-08-19 2016-07-14 Enzychem Lifesciences Corporation Compositions containing monoacetyldiacylglycerol compound as an active ingredient for preventing or treating rheumatoid arthritis
ES2752179T3 (en) 2014-05-15 2020-04-03 Enzychem Lifesciences Corp Methods of treating neutropenia
US9808438B2 (en) * 2015-11-09 2017-11-07 Enzychem Lifesciences Corporation Method for treating mucositis
SG11202103984WA (en) * 2018-10-23 2021-05-28 Japan Science & Tech Agency PPARd activator
WO2021248008A1 (en) 2020-06-05 2021-12-09 Innovation Pharmaceuticals Inc. Arylamide compounds for treatment and prevention of viral infections
MX2023014819A (en) 2021-06-14 2024-03-21 Scorpion Therapeutics Inc Urea derivatives which can be used to treat cancer.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6458777B1 (en) * 1998-03-13 2002-10-01 Mucosal Therapeutics Llc Methods and compositions for treating and preventing mucositis
ITTO20010110A1 (en) * 2001-02-08 2002-08-08 Rotta Research Lab NEW BENZAMIDINE DERIVATIVES EQUIPPED WITH ANTI-INFLAMMATORY AND IMMUNOSOPPRESSIVE ACTIVITY.

Also Published As

Publication number Publication date
ATE485819T1 (en) 2010-11-15
DK1704860T3 (en) 2011-02-07
AU2006226390B2 (en) 2011-09-08
ES2351665T3 (en) 2011-02-09
WO2006100204A1 (en) 2006-09-28
EP1704860A1 (en) 2006-09-27
EP1704860B1 (en) 2010-10-27
JP5020227B2 (en) 2012-09-05
AU2006226390A1 (en) 2006-09-28
CA2600773C (en) 2013-06-11
DE602005024357D1 (en) 2010-12-09
HK1095285A1 (en) 2007-05-04
PT1704860E (en) 2010-11-16
US20080194877A1 (en) 2008-08-14
JP2008534471A (en) 2008-08-28
CA2600773A1 (en) 2006-09-28

Similar Documents

Publication Publication Date Title
IL307201A (en) Triazine derivatives and their use in the treatment of cancer.
WO2004093831A3 (en) Cytokine-expressing cellular vaccine combinations
WO2004073630A3 (en) Anti-angiogenic and anti-tumoral properties of beta and gamma secretase inhibitors
ZA200802872B (en) Combination therapy comprising substituted oxazolidinones for the prevention and treatment of cerebral circulatory disorders
PT2030622E (en) Indication of dosage of progesterone in the treatment of a traumatic brain injury
AU2003249356A8 (en) Safe and effective nutritional supplement formulatins and associated regimens adapted to prevent and/or treat targeted diseases or medical or health conditions, and related methods
WO2000035475A3 (en) Method for the treatment of cerebral ischaemia and use of erythropoietin or erythropoietin derivatives for the treatment of cerebral ischaemia
WO2016025635A3 (en) Combination therapy for treating cancer
IL173123A0 (en) System and method for the photodynamic treatment of burns, wounds, and related skin disorders
WO2004096216A3 (en) Use of a topical medicament comprising riluzole
PL1704860T3 (en) Benzamidine derivatives for treatment and prevention of mucositis
PT2083837E (en) Therapeutic use of at least one botulic neurotoxin in the treatment of pain induced by at least one antineoplastic agent
WO2016043874A3 (en) Combination therapy for treating cancer
ZA200703697B (en) Use of ranolazone in combination with at least one remodeling agent for reversing left ventricular remodeling in the treatment of heart failure
IL280475A (en) A pharmaceutical composition for use in the treatment or prevention of a c5-related disease and a method for treating or preventing a c5-related disease
WO2008045378A3 (en) Treatment of infant hyperbilirubinemia using low dosages of stannsoporfin
WO2007062093A3 (en) Combination therapy for the treatment of cancer comprising a metalloprotease inhibitor
WO2006102375A3 (en) Methods for avoiding edema in the treatment or prevention of pparϝ-responsive diseases, including cancer
TW200724146A (en) Use of LGG in the manufacture of a medicament for the treatment, prevention or reduction of systemic inflammation in a formula-fed infant
IL282718A (en) Compounds for use in the treatment or prophylaxis of pain, inflammation and/or autoimmunity
GB0425633D0 (en) Topical formulations for use in the treatment or prevention of dermatological conditions
GB0427637D0 (en) Topical formulations for use in the treatment or prevention of skin cancers
Chefranova et al. Efficacy of mexidol in the combination with thrombolytic therapy in patients with ischemic stroke
TW200509925A (en) Method comprising irinotecan for treatment of breast cancer
HK40110527A (en) Inebilizumab and methods of using the same in the treatment or prevention of igg4-related disease